Frondoside a enhances the anti-cancer effects of oxaliplatin and 5-fluorouracil on colon cancer cells

Keyphrases

• Colon Cancer Cells 100%
• 5-fluorouracil (5-FU) 100%
• Oxaliplatin 100%
• Anticancer Effect 100%
• Frondoside A 100%
• Cell number 30%
• Phosphorylation 20%
• HCT116 20%
• Apoptosis Induction 20%
• Cytotoxic Drugs 20%
• High Concentration 10%
• Concentration-dependent 10%
• Synergize 10%
• Survival Kinases 10%
• Poly(ADP-ribose) Polymerase 10%
• HT-29 10%
• Colony Growth 10%
• Breast Cancer 10%
• Pancreatic Cancer 10%
• Inhibition Rate 10%
• Colorectal Cancer Cells 10%
• DNA Damage 10%
• Combination Treatment 10%
• Cisplatin 10%
• Human Pancreatic Cancer 10%
• Paclitaxel 10%
• Gemcitabine 10%
• Human Colon Cancer Cell Line 10%
• Colon Cancer 10%
• Lung Cancer 10%
• Cytotoxic Agents 10%
• Caspase-3 Activation 10%
• ERK2 10%
• Growth in Vitro 10%
• Apoptotic Effect 10%
• Atlantic Sea Cucumber 10%
• Triterpene Glycosides 10%
• H2AX 10%
• Colon Surgery 10%
• Human Lung Cancer 10%
• Human Breast Cancer 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Fluorouracil 100%
• Oxaliplatin 100%
• Colon Cancer 100%
• Cytotoxic Agent 37%
• Pancreas Cancer 25%
• Breast Cancer 25%
• Lung Cancer 25%
• Phosphotransferase 12%
• Cisplatin 12%
• Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 12%
• Glycoside 12%
• Caspase 3 12%
• Paclitaxel 12%
• Gemcitabine 12%
• Mitogen Activated Protein Kinase 3 12%
• Sea Cucumber 12%
• Triterpenoid 12%